International Joint Center for Biomedical Innovation (JCBI)     International Joint Center for Biomedical Innovation (JCBI)
Position: JCBI HOME/News/Content
Dr. David Lovejoy visited JCBI

Dr. David Lovejoy visited JCBI on 31th October and shared his recent research entitled “The kynurenine pathway is Alzheimer’s Disease: biomarker and drug discovery”, as well as his experience on English academic writing.

Dr. David Lovejoy has been engaged in research on medical chemistry and biomedical. By far, he has more than 50 publications in top ranked international research journals including Blood, Cancer Research etc. He has led or participated in more than 30 scientific research projects and was accredited 2 patents. Dr. David Lovejoy also equipped with extensive experience in the application of scientific research results. The cancer treatment molecule: DpC, which was designed and synthesized by Lovejoy himself, has engaged in phase 1 clinical trials. In addition, Dr. David Lovejoy founded Oncochel Therapeutics LLC (USA), a company dedicated to translating scientific research in biomedical related fields into social benefits.

 International Joint Center
for Biomedical Innovation (JCBI)
School of Life Sciences, Henan University, Jin Ming Avenue, Kaifeng, Henan, 475004, China